Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Sceppa
Phase II Study of Monthly Pasireotide LAR (SOM230C) for Recurrent or Progressive Meningioma.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Phase II Study of Bevacizumab and Pemetrexed for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Meningioma Imitating Progressive Aphasia
Journal of the Korean Neurological Association
A Phase II Study of Axalimogene Filolisbac for Patients With Previously Treated, Unresectable, Persistent/Recurrent Loco-Regional or Metastatic Anal Cancer
Oncotarget
Oncology
Phase II Evaluation of Intravenous Vinorelbine (Navelbine) in Recurrent or Refractory Pediatric Malignancies: A Children's Oncology Group Study
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Phase II Evaluation of Dasatinib in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Erratum To: Pasireotide LAR Maintains Inhibition of GH and IGF-1 in Patients With Acromegaly for Up to 25 Months: Results From the Blinded Extension Phase of a Randomized, Double-Blind, Multicenter, Phase III Study
Pituitary
Endocrinology
Metabolism
Diabetes
A Retrospective Study on Combination Therapy With Ifosfamide, Adriamycin and Cisplatin for Progressive or Recurrent Uterine Sarcoma
Molecular and Clinical Oncology
Cancer Research
Oncology
A Phase II Evaluation of Lapatinib in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
